Insmed Incorporated

NasdaqGS:INSM Stok Raporu

Piyasa değeri: US$13.1b

Insmed Yönetim

Yönetim kriter kontrolleri 3/4

Insmed CEO'su Will Lewis, Sep2012 tarihinde atandı, in görev süresi 12.17 yıldır. in toplam yıllık tazminatı $ 10.41M olup, şirket hissesi ve opsiyonları dahil olmak üzere 7.5% maaş ve 92.5% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.25% ine doğrudan sahiptir ve bu hisseler $ 32.89M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 5 yıl ve 10.5 yıldır.

Anahtar bilgiler

Will Lewis

İcra Kurulu Başkanı

US$10.4m

Toplam tazminat

CEO maaş yüzdesi7.5%
CEO görev süresi12.2yrs
CEO sahipliği0.3%
Yönetim ortalama görev süresi5yrs
Yönetim Kurulu ortalama görev süresi10.5yrs

Son yönetim güncellemeleri

Recent updates

Insmed: PAH Treatment Advancement With 2nd Half 2025 Top-Line Data

Nov 20

Insmed Incorporated's (NASDAQ:INSM) Share Price Not Quite Adding Up

Sep 12
Insmed Incorporated's (NASDAQ:INSM) Share Price Not Quite Adding Up

Insmed: Brensocatib Propels Stock As Regulatory Milestones Approach

Aug 28

Is Insmed (NASDAQ:INSM) A Risky Investment?

Aug 10
Is Insmed (NASDAQ:INSM) A Risky Investment?

Insmed Incorporated's (NASDAQ:INSM) 92% Share Price Surge Not Quite Adding Up

May 29
Insmed Incorporated's (NASDAQ:INSM) 92% Share Price Surge Not Quite Adding Up

Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade)

May 28

Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Feb 25
Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Dec 18
Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Jul 28
Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Jul 01
Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

Apr 18
Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Feb 23
A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Insmed inks financing agreements to raise $500M

Oct 19

Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

Oct 17
Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Sep 20
An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Insmed rises 16% on better-than-expected Q2 result

Aug 04

CEO Tazminat Analizi

Will Lewis'un ücretlendirmesi Insmed'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$864m

Jun 30 2024n/an/a

-US$803m

Mar 31 2024n/an/a

-US$747m

Dec 31 2023US$10mUS$780k

-US$750m

Sep 30 2023n/an/a

-US$724m

Jun 30 2023n/an/a

-US$696m

Mar 31 2023n/an/a

-US$547m

Dec 31 2022US$8mUS$735k

-US$482m

Sep 30 2022n/an/a

-US$434m

Jun 30 2022n/an/a

-US$416m

Mar 31 2022n/an/a

-US$438m

Dec 31 2021US$7mUS$710k

-US$435m

Sep 30 2021n/an/a

-US$424m

Jun 30 2021n/an/a

-US$375m

Mar 31 2021n/an/a

-US$319m

Dec 31 2020US$6mUS$660k

-US$294m

Sep 30 2020n/an/a

-US$245m

Jun 30 2020n/an/a

-US$242m

Mar 31 2020n/an/a

-US$247m

Dec 31 2019US$7mUS$641k

-US$254m

Sep 30 2019n/an/a

-US$293m

Jun 30 2019n/an/a

-US$320m

Mar 31 2019n/an/a

-US$330m

Dec 31 2018US$6mUS$610k

-US$324m

Sep 30 2018n/an/a

-US$298m

Jun 30 2018n/an/a

-US$256m

Mar 31 2018n/an/a

-US$224m

Dec 31 2017US$4mUS$567k

-US$193m

Tazminat ve Piyasa: Will 'ın toplam tazminatı ($USD 10.41M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 12.66M ).

Tazminat ve Kazançlar: Will şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.


CEO

Will Lewis (55 yo)

12.2yrs

Görev süresi

US$10,411,260

Tazminat

Mr. William H. Lewis, also known as Will, J.D. M.B.A. serves as an Independent Chairman of Board of Directors of NewAmsterdam Pharma Company N.V. from January 2024. He has been Chief Executive Officer and...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
William Lewis
President12.2yrsUS$10.41m0.25%
$ 32.9m
Sara Bonstein
Chief Financial Officer4.8yrsUS$4.56m0.010%
$ 1.3m
Roger Adsett
Chief Operating Officer5yrsUS$4.01m0.036%
$ 4.6m
John Wise
Chief Commercial Officer5yrsUS$3.89m0.029%
$ 3.8m
Martina Flammer
Chief Medical Officer4.9yrsUS$4.22m0.0071%
$ 929.2k
Brian Kaspar
Chief Scientific Officerno dataVeri yokVeri yok
Eleanor Barisser
Associate Director of Investor Relationsno dataVeri yokVeri yok
Michael Smith
Chief Legal Officer & Corporate Secretary3.3yrsVeri yok0.038%
$ 5.0m
Mandy Fahey
Executive Director of Corporate Communicationsno dataVeri yokVeri yok
S. Schaeffer
Chief People Strategy Officer11.8yrsUS$2.66m0.019%
$ 2.5m
Eugene Sullivan
Chief Product Strategy Officer7.5yrsUS$1.69mVeri yok
Neil Hughes
GM & Head of Europe5.4yrsVeri yokVeri yok

5.0yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim: INSM 'un yönetim ekibi deneyimli ve deneyimlidir ( 5 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
William Lewis
President12.2yrsUS$10.41m0.25%
$ 32.9m
David W. McGirr
Independent Director11.1yrsUS$320.00k0.048%
$ 6.3m
Melvin Sharoky
Independent Director23.5yrsUS$312.50k0.18%
$ 23.8m
Alfred Altomari
Independent Director12.3yrsUS$320.00k0.031%
$ 4.1m
David Brennan
Lead Independent Director10.5yrsUS$345.00k0.061%
$ 8.0m
Clarissa Desjardins
Independent Director5yrsUS$315.00k0.027%
$ 3.6m
Elizabeth Anderson
Independent Director6yrsUS$310.00k0.031%
$ 4.1m
Leo Lee
Independent Director6.5yrsUS$317.50k0.062%
$ 8.2m
Carol Schafer
Independent Director4.6yrsUS$315.00k0.025%
$ 3.3m

10.5yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: INSM 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 10.5 yıldır).